Increased risk of myocardial infarction as first manifestation of ischaemic heart disease and nonselective nonsteroidal anti-inflammatory drugs.

MLA

Hawkey, C. J., et al. “Increased Risk of Myocardial Infarction as First Manifestation of Ischaemic Heart Disease and Nonselective Nonsteroidal Anti-Inflammatory Drugs.” British Journal of Clinical Pharmacology, vol. 61, no. 6, June 2006, pp. 730–37. EBSCOhost, https://doi.org/10.1111/j.1365-2125.2006.02644.x.

APA

Hawkey, C. J., Hawkey, G. M., Everitt, S., Skelly, M. M., Stack, W. A., & Gray, D. (2006). Increased risk of myocardial infarction as first manifestation of ischaemic heart disease and nonselective nonsteroidal anti-inflammatory drugs. British Journal of Clinical Pharmacology, 61(6), 730–737. https://doi.org/10.1111/j.1365-2125.2006.02644.x

Chicago

Hawkey, C J, G M Hawkey, S Everitt, M M Skelly, W A Stack, and D Gray. 2006. “Increased Risk of Myocardial Infarction as First Manifestation of Ischaemic Heart Disease and Nonselective Nonsteroidal Anti-Inflammatory Drugs.” British Journal of Clinical Pharmacology 61 (6): 730–37. doi:10.1111/j.1365-2125.2006.02644.x.